
CAS Name: [4S-(4a,4aa,5aa,6b,12aa)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-6-methyl-1,11-dioxo-2-naphthacenecarbox...
Literature References: Semi-synthetic broad spectrum antibiotic related to tetracycline. Prepn: Pedrazzoli et al., Boll. Chim. Farm. 98, 516 (1959), C.A. 54, 3856a (1960); Gradnik et al., GB 888968 corresp to US 3149114 (1962 and 1964 to E.R.A.S.M.E.). Properties: eidem, Pharm. Acta Helv. 35, 529 (1960). Pharmacokinetic studies: A. Scalvini, A. Delmonte, Gazz. Med. Ital. 131, 1 (1972).
CAS Name: (6R,7S)-7-[[[[(2S)-2-Amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Addition...
Literature References: Semisynthetic broad spectrum cephamycin antibiotic. Prepn: BE 880656, K. Iwamatsu et al., US 4357331 (1980, 1982 both to Meiji Seika). Synthesis, biological activity: eidem, J. Antibiot. 36, 229 (1983). Structure-activity studies: S. Inouye et al., ibid. 37, 1403 (1984). Proposed mechanism of action: T. Tsuruoka et al., Eur. J. Biochem. 151, 209 (1985). In vitro, in vivo antibacterial activity compared with that of other cephalosporins: S. Inouye et al., Antimicrob. Agents Chemother. 26, 722 (1984). Activity against gram-negative infections in mice: T. Watanabe et al., Drugs Exp. Clin. Res. 10, 293 (1984). Toxicity studies: M. Kurebe et al., Jpn. J. Antibiot. 37, 847 (1984). Series of articles on pharmacokinetics, early clinical trials, treatment of urinary tract and respiratory infections: Chemotherapy (Tokyo) 32, Suppl. 5 (1984) 561 pp.
CAS Name: (4S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Additional Names: 9-nitrocamptothecin; 9-nitro-(20S)-camptothecin; 9-NC
Trademarks...
Literature References: Semisynthetic camptothecin which inhibits DNA topoisomerase I. Prodrug of 9-aminocamptothecin, (9-AC), q.v. Prepn: JP Kokai 59 51288 (1984 to Yakult Honsha), C.A. 101, 91322 (1984); M. C. Wani et al., J. Med. Chem. 29, 2358 (1986); and activity: S. Sawada et al., Chem. Pharm. Bull. 39, 3183 (1991). Conversion to 9-AC by human cells: P. Pantazis et al., Eur. J. Haematol. 53, 246 (1994); eidem, ibid. 55, 211 (1995). Clinical trial in pancreatic cancer: J. S. Stehlin et al., Int. J. Oncol. 14, 821 (1999). Review: C. F. Verschraegen, Curr. Opin. Oncol. Endocr. Metab. Invest. Drugs 1, 184-190 (1999).
CAS Name: (6R,7R)-7-[[(2R)-Aminophenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate
Additional Names: 7-(D-2-amino-2-phenylacetamido)-3-chloro-3...
Literature References: Semi-synthetic cephalosporin antibiotic, related to cephalexin, q.v. Prepn: R. R. Chauvette, DE 2408698 (1974 to Lilly), C.A. 82, 4278n (1975); US 3925372 (1975 to Lilly); R. R. Chauvette, P. A. Pennington, J. Med. Chem. 18, 403 (1975). In vitro studies: M. S. Silver et al., Antimicrob. Agents Chemother. 12, 591 (1977); R. N. Jones, J. Antibiot. 30, 753 (1977); B. R. Meyers, S. Z. Hirschman, J. Clin. Pharmacol. 18, 85 (1978). Metabolism: N. G. Waterman, L. F. Sharfenberger, Antimicrob. Agents Chemother. 14, 614 (1978). Human pharmacology: G. R. Hodges et al., ibid. 454; A. Glynne et al., J. Antimicrob. Chemother. 4, 343 (1978). Clinical studies: J. D. Nelson et al., Am. J. Dis. Child. 132, 992 (1978); B. M. Gray et al., Antimicrob. Agents Chemother. 13, 988 (1978). Comprehensive description: L. J. Lorenz, Anal. Profiles Drug Subs. 9, 107-123 (1980).
CAS Name: (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2R)-aminophenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional Names: 7-(2-amino-2-phenylacetamido)-3-(hydroxym...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: BE 635137; F. W. Wall et al., US 3422103 (1964, 1969 both to Glaxo); GB 1017624 (1966 to Merck Co.); Spencer et al., J. Med. Chem. 9, 746 (1966); of D- and DL-forms: GB 985747 (1965 to Lilly); Kurita et al., J. Antibiot. 19A, 243 (1966). Metabolism and pharmacokinetics in man: J. Haginaka et al., J. Antibiot. 33, 236 (1980).
CAS Name: 1-[[(6R,7R)-2-Carboxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]pyridinium inner salt
Additional Names: 1-[(7'-b-[2-(2-thienyl)acetamido]-8'-oxo-...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: FR 1384197 (1965 to Glaxo), C.A. 63, 11591c (1965); E. H. Flynn, US 3449338 (1969 to Lilly). Toxicity studies: Atkinson et al., Toxicol. Appl. Pharmacol. 8, 398 (1966).
CAS Name: (6R,7R)-3-[(Acetyloxy)methyl]-7-[(cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monosodium salt
Additional Names: sodium 7-(2-cyanoacetamido)-3-(hydro...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: NL 6600586; Bickel et al., US 3483197 (1966, 1969 both to Ciba). Activity studies: Knüsel et al., Antimicrob. Agents Chemother. 1970, 140; Neu et al., J. Antibiot. 25, 400 (1972). Pharmacokinetics and clinical results: Kradolfer et al., Schweiz. Med. Wochenschr. 103, 711 (1973); Riess et al., ibid. 718. Toxicology: Kradolfer et al., Antimicrob. Agents Chemother. 1970, 150. Review: Arzneim.-Forsch. 24, 1446-1533 (1974).
CAS Name: (6R,7R)-7-[[(2R)-Amino-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate
Additional Names: 7-[D-(-)-a-amino-a-(4-hydroxyp...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: NL 6812382; L. B. Crast, Jr., US 3489752 (1969, 1970 both to Bristol-Myers); T. Takahashi et al., DE 2216113; eidem, US 3816253 (1972, 1974, both to Takeda). Prepn of crystalline monohydrate: D. Bouzard et al., US 4504657 (1985 to Bristol-Myers). Antimicrobial activity: R. E. Buck, K. E. Price, Antimicrob. Agents Chemother. 11, 324 (1977). Pharmacology: M. Pfeffer et al., ibid. 331; A. I. Hartstein et al., ibid. 12, 93 (1977). Review: J. Antimicrob. Chemother. 10, Suppl. B, 1-162 (1982). Series of articles on clinical trials in respiratory tract infections: Drugs 32, Suppl. 3, 1-56 (1986).
CAS Name: (6R,7R)-3-[(Acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional Names: 3-(hydroxymethyl)-8-oxo-7-[2-(2-thienyl)acetamid...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: Chauvette et al., J. Am. Chem. Soc. 84, 3401 (1962); E. H. Flynn, US 3218318 (1965 to Lilly); FR 1384197 (1965 to Glaxo), C.A. 63, 11591c (1965). Bacteriology and pharmacology: Lee, Anderson, Antimicrob. Agents Chemother. 1962, 695; Walters et al., ibid. 706; Naumann, Arzneim.-Forsch. 16, 1099 (1966). Acute toxicity: M. Kuramoto et al., Jpn. J. Antibiot. 27, 746 (1974), C.A. 83, 71972t (1975). Comprehensive description: R. J. Simmons, Anal. Profiles Drug Subs. 1, 319-341 (1972).
CAS Name: (6R,7R)-7-[[(2R)-Aminophenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional Names: 7-(D-a-aminophenylacetamido)desacetoxycephalosporanic ...
Literature References: Semi-synthetic cephalosporin antibiotic. Prepn: R. B. Morin, B. G. Jackson, US 3275626; US 3507861 (1966, 1970 both to Lilly); Ryan et al., J. Med. Chem. 12, 310 (1969). Pharmacology and toxicology: Muggleton et al., Antimicrob. Agents Chemother. 1968, 353; Kind et al., Welles et al., ibid. 361, 489. Comprehensive description: L. P. Marrelli, Anal. Profiles Drug Subs. 4, 21-46 (1975). Clinical pharmacology, efficacy, adverse reactions: Postgrad. Med. J. 59, Suppl. 5, 1-56 (1983).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
